Gilead Sciences (GILD) says it's submitted a New Drug Application to the FDA for marketing...

|About: Gilead Sciences, Inc. (GILD)|By:, SA News Editor

Gilead Sciences (GILD) says it's submitted a New Drug Application to the FDA for marketing approval of cobicistat, a boosting agent that increases blood levels of certain commercially available protease inhibitors to enable once-daily dosing. Cobicistat is also a component of the Quad once-daily single tablet regimen for HIV, which is currently under U.S. and European regulatory review.